BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21250804)

  • 1. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.
    El Hindy N; Bachmann HS; Lambertz N; Adamzik M; Nückel H; Worm K; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
    J Neurosurg; 2011 Jun; 114(6):1631-9. PubMed ID: 21250804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
    Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
    Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
    Hirata H; Hinoda Y; Nakajima K; Kikuno N; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
    J Urol; 2009 Aug; 182(2):721-7. PubMed ID: 19539330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the GNAS1 T393C polymorphism in patients with glioblastoma multiforme.
    El Hindy N; Lambertz N; Bachmann HS; Frey UH; Adamzik M; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
    J Clin Neurosci; 2011 Nov; 18(11):1495-9. PubMed ID: 21924916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme.
    El Hindy N; Adamzik M; Lambertz N; Bachmann HS; Worm K; Egensperger R; Frey UH; Asgari S; Sure U; Siffert W; Sandalcioglu IE
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1423-9. PubMed ID: 20145952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.
    Bachmann HS; Heukamp LC; Schmitz KJ; Hilburn CF; Kahl P; Buettner R; Nückel H; Eisenhardt A; Rübben H; Schmid KW; Siffert W; Eggert A; Schramm A; Schulte JH
    Int J Cancer; 2011 Nov; 129(10):2390-9. PubMed ID: 21207420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional Aquaporin 1 -783G/C-polymorphism is associated with survival in patients with glioblastoma multiforme.
    El Hindy N; Rump K; Lambertz N; Zhu Y; Frey UH; Bankfalvi A; Siffert W; Sure U; Peters J; Adamzik M; Sandalcioglu IE
    J Surg Oncol; 2013 Dec; 108(7):492-8. PubMed ID: 24014128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
    Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
    Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.
    Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Kelava A; Nückel H; Lang S; Schmid KW; Siffert W; Bachmann HS
    Ann Oncol; 2009 Jun; 20(6):1094-9. PubMed ID: 19196738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional polymorphism in the pre‑miR‑146a gene influences the prognosis of glioblastoma multiforme by interfering with the balance between Notch1 and Notch2.
    Liu R; Li W; Wu C
    Mol Med Rep; 2015 Oct; 12(4):5475-81. PubMed ID: 26165719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
    Khatri RG; Navaratne K; Weil RJ
    J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL2 genotypes and prostate cancer survival.
    Renner W; Langsenlehner U; Krenn-Pilko S; Eder P; Langsenlehner T
    Strahlenther Onkol; 2017 Jun; 193(6):466-471. PubMed ID: 28396899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
    Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancer.
    Heubner M; Wimberger P; Otterbach F; Kasimir-Bauer S; Siffert W; Kimmig R; Nückel H
    Int J Biol Markers; 2009; 24(4):223-9. PubMed ID: 20082279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
    Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
    Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
    Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W
    Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population.
    Li W; Qian C; Wang L; Teng H; Zhang L
    Tumour Biol; 2014 Mar; 35(3):2259-64. PubMed ID: 24287948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
    Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
    World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder.
    Hess J; Stelmach P; Eisenhardt A; Rübben H; Reis H; Schmid KW; Bachmann HS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1659-1670. PubMed ID: 28417194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.